As a proof-of-concept for this strategy in IRDs, CRISPR-Cas9 editing approaches have been used to generate NHEJ-mediated disruption of the mutated rhodopsin gene [RHO]. The gene discussed is RHO; the disease is respiratory distress syndrome in premature infants.